<code id='7544CDBBE6'></code><style id='7544CDBBE6'></style>
    • <acronym id='7544CDBBE6'></acronym>
      <center id='7544CDBBE6'><center id='7544CDBBE6'><tfoot id='7544CDBBE6'></tfoot></center><abbr id='7544CDBBE6'><dir id='7544CDBBE6'><tfoot id='7544CDBBE6'></tfoot><noframes id='7544CDBBE6'>

    • <optgroup id='7544CDBBE6'><strike id='7544CDBBE6'><sup id='7544CDBBE6'></sup></strike><code id='7544CDBBE6'></code></optgroup>
        1. <b id='7544CDBBE6'><label id='7544CDBBE6'><select id='7544CDBBE6'><dt id='7544CDBBE6'><span id='7544CDBBE6'></span></dt></select></label></b><u id='7544CDBBE6'></u>
          <i id='7544CDBBE6'><strike id='7544CDBBE6'><tt id='7544CDBBE6'><pre id='7544CDBBE6'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:972
          WuXi AppTec company logo on a phone screen against a backgroud showing stock graph — coverage from STAT
          Adobe

          WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

          It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

          advertisement

          WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          BMS, looking to build heart drug business, turns to AI for diagnosis
          BMS, looking to build heart drug business, turns to AI for diagnosis

          AdobeAsBristolMyersSquibbworkstobuilditstreatmentforaheartconditionthatcancausedifficultybreathingin

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Medicare’s new pay boost for primary care is angering specialists

          AdobeWASHINGTON—DoctorsarestaringdownacuttotheirMedicarepaynextyear,andwhilethenewshasunitedtheminou